Matrixome

Matrixome

Matrixome - an innovative technology that brings brings ECM molecules together.

Founded 2015 Japan

Japan 3 employees Venture round Total: $275.00M Biotechnology

Matrixome is a biotechnology startup founded in 2015, stemming from the pioneering work of Professor Kiyotoshi Sekiguchi at Osaka University. The company's slogan, "Matrixome - an innovative technology that brings ECM molecules together," encapsulates its innovative approach to working with extracellular matrix (ECM) molecules. The term 'matrixome' refers to a comprehensive array of ECM molecules that shape the specialized microenvironments of distinct cell types. Matrixome, Inc. was established with the primary objective of studying the matrixome and exploring its potential applications. In February 2016, Matrixome secured a substantial ¥275.00M Venture Round investment from prominent backers, including SMBC Venture Capital, Osaka University Venture Capital, and Nippi. This noteworthy investment underscores the confidence that key industry players have in Matrixome's innovative technology and research endeavors. With this strong financial backing, Matrixome is well-positioned to further advance its groundbreaking work in the biotechnology sphere, potentially paving the way for impactful developments in the field of ECM research and its diverse applications.

Funding Stage	Amount	Investors	Lead Investors	Date
Venture Round	¥275.00M	3	SMBC Venture Capital, Osaka University Venture Capital +1	01 Feb 2016

Funding Stage

Amount

Investors

Lead Investors

Date

Venture Round

¥275.00M

SMBC Venture Capital, Osaka University Venture Capital +1

01 Feb 2016

FAQ About Matrixome

Matrixome - an innovative technology that brings brings ECM molecules together.

Matrixome was founded in 2015.

Matrixome is headquartered in Japan.

Matrixome operates in Biotechnology. Its work centres on Extracellular matrix technology, Biomolecular research, Cellular microenvironment analysis and Proteomics.

Matrixome has approximately 3 employees.

Matrixome has completed 1 funding round, raising a total of $275.00M. The latest funding stage is Venture round.

Top alternatives and competitors to Matrixome include Halo Biosciences, KTK BIOTECH , BioVendor Research & Diagnostic Products, Sutura Therapeutics Ltd, Inoviv. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Matrixome and Halo Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Matrixome

Funding Rounds & Investors (1)

Matrixome Alternatives & Competitors

FAQ About Matrixome